Key result
A 66-year-old man with COVID-19 and mechanical prosthetic valves developed catastrophic Candida tropicalis endocarditis and died of septic shock shortly after receiving antifungal therapy.
Why the study?
COVID-19 and Candida prosthetic valve endocarditis present overlapping clinical manifestations, making discrimination between them extremely difficult.
Case Report (n=1)
Highlights the diagnostic challenge and fatal outcome of Candida prosthetic valve endocarditis co-occurring with COVID-19, emphasizing the need for early diagnosis.
Answers are grounded in this paper and cite their sources.
May warrant heightened vigilance for Candida endocarditis in COVID-19 prosthetic valve patients; leaves open optimal diagnostic and therapeutic approaches.
Background and Purpose: Coronavirus disease 2019 (COVID-19) and Candida prostatic valve endocarditis present various clinical manifestations which may overlap;hence, discrimination between them is extremely difficult. Case report: The case was a 66-year-old man with a past medical history of mitral and aortic valves replacement one year before COVID-19 co-infection. He was admitted with fever (for 7 days), shortness of breath, cough, seizure, lethargy,headache, and 85% oxygen saturation. Transesophageal echocardiography revealed multiple large-sized, highly mobile masses on both sides of the mechanical mitral valve highly suggestive of vegetation. Chest computed tomography scanning showed simulating scattered COVID-19 peripheral ground-glass opacities confirmed by reverse-transcription polymerase chain reaction. The set of blood cultures yielded yeast colonies that were identified as Candida tropicalis. The patient died of septic shock shortly after receiving antifungal therapy. Conclusion: This case emphasized the importance of early diagnosis and implementation of antifungal treatment, particularly in patients with prosthetic cardiac valves, to reduce their unfavorable outcomes in COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Davoodi et al. (2021) conducted a case report in Candida prosthetic valve endocarditis and COVID-19 (n=1). Antifungal therapy (Liposomal amphotericin B) was evaluated on Clinical outcome (survival). A 66-year-old man with COVID-19 and mechanical prosthetic valves developed catastrophic Candida tropicalis endocarditis and died of septic shock shortly after receiving antifungal therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: